ERFSF
Price
$77.36
Change
-$4.78 (-5.82%)
Updated
Jul 28 closing price
Capitalization
13.29B
MTD
Price
$1267.98
Change
+$6.95 (+0.55%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
28.69B
2 days until earnings call
Interact to see
Advertisement

ERFSF vs MTD

Header iconERFSF vs MTD Comparison
Open Charts ERFSF vs MTDBanner chart's image
Eurofins Scientific Nante
Price$77.36
Change-$4.78 (-5.82%)
Volume$2.08K
Capitalization13.29B
Mettler-Toledo International
Price$1267.98
Change+$6.95 (+0.55%)
Volume$1.12K
Capitalization28.69B
ERFSF vs MTD Comparison Chart in %
Loading...
ERFSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERFSF vs. MTD commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERFSF is a Buy and MTD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (ERFSF: $77.36 vs. MTD: $1261.03)
Brand notoriety: ERFSF and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ERFSF: 161% vs. MTD: 102%
Market capitalization -- ERFSF: $13.29B vs. MTD: $28.69B
ERFSF [@Medical Specialties] is valued at $13.29B. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERFSF’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • ERFSF’s FA Score: 1 green, 4 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, ERFSF is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERFSF’s TA Score shows that 4 TA indicator(s) are bullish while MTD’s TA Score has 5 bullish TA indicator(s).

  • ERFSF’s TA Score: 4 bullish, 4 bearish.
  • MTD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MTD is a better buy in the short-term than ERFSF.

Price Growth

ERFSF (@Medical Specialties) experienced а +7.45% price change this week, while MTD (@Medical Specialties) price change was +8.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.36%. For the same industry, the average monthly price growth was +2.35%, and the average quarterly price growth was -4.23%.

Reported Earning Dates

MTD is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-1.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($28.7B) has a higher market cap than ERFSF($13.3B). MTD has higher P/E ratio than ERFSF: MTD (37.36) vs ERFSF (19.27). ERFSF YTD gains are higher at: 47.480 vs. MTD (3.052). ERFSF has higher annual earnings (EBITDA): 1.49B vs. MTD (1.17B). ERFSF has more cash in the bank: 487M vs. MTD (69.8M). MTD has less debt than ERFSF: MTD (2.08B) vs ERFSF (3.33B). ERFSF has higher revenues than MTD: ERFSF (6.71B) vs MTD (3.79B).
ERFSFMTDERFSF / MTD
Capitalization13.3B28.7B46%
EBITDA1.49B1.17B127%
Gain YTD47.4803.0521,556%
P/E Ratio19.2737.3652%
Revenue6.71B3.79B177%
Total Cash487M69.8M698%
Total Debt3.33B2.08B160%
FUNDAMENTALS RATINGS
ERFSF vs MTD: Fundamental Ratings
ERFSF
MTD
OUTLOOK RATING
1..100
1817
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
8856
SMR RATING
1..100
943
PRICE GROWTH RATING
1..100
3852
P/E GROWTH RATING
1..100
7482
SEASONALITY SCORE
1..100
6511

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ERFSF's Valuation (18) in the null industry is significantly better than the same rating for MTD (98) in the Medical Specialties industry. This means that ERFSF’s stock grew significantly faster than MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (56) in the Medical Specialties industry is in the same range as ERFSF (88) in the null industry. This means that MTD’s stock grew similarly to ERFSF’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for ERFSF (94) in the null industry. This means that MTD’s stock grew significantly faster than ERFSF’s over the last 12 months.

ERFSF's Price Growth Rating (38) in the null industry is in the same range as MTD (52) in the Medical Specialties industry. This means that ERFSF’s stock grew similarly to MTD’s over the last 12 months.

ERFSF's P/E Growth Rating (74) in the null industry is in the same range as MTD (82) in the Medical Specialties industry. This means that ERFSF’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ERFSFMTD
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 5 days ago
61%
Declines
ODDS (%)
Bearish Trend 16 days ago
62%
Bearish Trend 9 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ERFSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RBUF27.810.01
+0.02%
Innovator U.S. Small Cp 10 Buf ETF - Qt
SPMB21.86-0.04
-0.18%
SPDR® Portfolio Mortgage Backed Bond ETF
KVLE26.51-0.09
-0.34%
KraneShares Value Line® Dyn Div Eq ETF
FRI27.11-0.45
-1.64%
First Trust S&P REIT ETF
FDT69.85-1.18
-1.66%
First Trust Dev Mkts Ex-US AlphaDEX® ETF

ERFSF and

Correlation & Price change

A.I.dvisor tells us that ERFSF and SOAGY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERFSF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERFSF
1D Price
Change %
ERFSF100%
-5.81%
SOAGY - ERFSF
24%
Poorly correlated
-0.51%
SAUHY - ERFSF
22%
Poorly correlated
-2.32%
MHUA - ERFSF
22%
Poorly correlated
+2.97%
OLYMY - ERFSF
20%
Poorly correlated
+0.16%
MTD - ERFSF
20%
Poorly correlated
-0.23%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
-0.23%
A - MTD
85%
Closely correlated
-0.53%
RVTY - MTD
78%
Closely correlated
-8.32%
TMO - MTD
76%
Closely correlated
+1.39%
BRKR - MTD
73%
Closely correlated
+4.74%
WAT - MTD
72%
Closely correlated
-0.19%
More